As our nation attempts to pick itself up and walk away from the COVID battlefield, we can see the toll it has suffered. COVID spurred a pervasive physical and mental health crisis in the United States, but it has also precipitated a financial and operational crisis among our most important healthcare institutions.
Renata Maia joins the agency from IPG Health’s award-winning AREA 23.
The development is the latest in SCIRIS’ rapid expansion, having over the last two years acquired six agencies with considerable scientific and commercial expertise on both sides of the Atlantic.
We know that a lack of diversity in healthcare settings can lead to harmful disparities in health outcomes, but a lack of diversity in messaging can also make people less likely to seek care in the first place. While social media influencers are working to change narratives and correct harmful assumptions around race, gender, and sex in the medical field, every sector of healthcare can work to understand the importance of diversity, conquer biases and stigma, and improve representation.
One of the advantages of leveraging behavioral science in healthcare marketing is that it provides marketers with powerful tools to do what we do best: solve problems. Once we are able to identify the unique behavioral barriers at play, the science leads us toward solutions that are likely to be successful in addressing them. But what happens when we are faced with behavioral challenges that are not so clearly solvable?
Jazz Pharmaceuticals plc announced new real-world data from the BECOME (BEhavior, COgnition, and More with Epidiolex) Caregiver Survey that showed a substantial proportion of caregivers of adult and pediatric patients with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) prescribed Epidiolex (cannabidiol) oral solution reported improvements in patients’ seizure and non-seizure outcomes across all age groups.
Lumanity’s deep data analytics, value demonstration, and therapeutic area expertise alongside HealthVerity’s patient identity resolution technology and leading ecosystem of interoperable real-world data enables evidence generation across the pharma lifecycle.
Learn about moving the MSL-KOL relationships from perfunctory to powerful. Join the featured speakers in reviewing the importance of KOL Identification and management and learn how to leverage the right technology and tools to create a quality engagement.
Clarify Health, a leading cloud analytics and value-based payments platform company, and Datavant, the leader in helping organizations securely connect health data, today announced an expanded collaboration to enable life sciences companies to connect their proprietary, first-party data in Clarify’s AI-powered Atlas analytics platform to improve clinical development and commercial operations.
While preventive care is vital to the well-being of all types of patients, members of the lesbian, gay, bisexual, transgender and queer and/or questioning community face unique barriers that impact their preventive health awareness and access – setting many of them up for poorer overall health outcomes and even impacting their trust in pharma.